Christopher M DaCosta Selected Research

Christopher M DaCosta Research Topics

3	Type 2 Diabetes Mellitus (MODY) 08/2014 - 10/2009
2	Obesity 01/2021 - 01/2020
1	Insulin Resistance 01/2022
1	Sarcopenia 01/2020
1	Muscular Diseases (Myopathy) 01/2020
1	Diarrhea 01/2017
1	Experimental Diabetes Mellitus 01/2017
1	Body Weight (Weight, Body) 08/2014
1	Hyperphagia (Overeating) 08/2014
1	Weight Gain 08/2014
1	Weight Loss (Weight Reduction) 08/2014
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2011

4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2009
2	Insulin (Novolin)FDA Link 01/2022 - 08/2014
1	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2017
1	Resistant StarchIBA 01/2017
1	LX2761IBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	Blood Glucose (Blood Sugar)IBA 08/2014
1	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 08/2014
1	Proteins (Proteins, Gene)FDA Link 01/2011
1	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2009
1	SodiumIBA 10/2009
1	Xylose (D-Xylose)FDA Link 10/2009

2	Glycemic Control 08/2014 - 01/2013
1	Therapeutics 01/2021